There is a real opportunity for pharma to support the under-served population of atopic dermatitis patients, writes Mariel Metcalfe.
Mariel Metcalfe
Advertisement
Mariel Metcalfe (marielm@researchpartnership.com) is Head of Living With at Research Partnership.
Articles by Mariel Metcalfe
Advertisement
Latest Updated Articles
Atopic Dermatitis — Going Beyond the PillApril 23rd 2018
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Agentic AI and the Future of Commercial Excellence in Life Sciences
3
What is Shadow AI and How is it Impacting Pharma Companies?
4
Americans Cutback on Expenses to Cover Healthcare Costs: Report
5